Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

"Over more than 15 years of follow-up, both patients remained relapse-free without ongoing immunosuppression, accompanied by ...

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

So with digital habits eroding our ability to concentrate, there's a new trend here to combat it: “attention-span-maxxing.” ...

Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...

Sure, here is the description with all links and additional text removed: If you found this video enjoyable, kindly show your ...

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

The MKULTRA Project involved some of the most controversial experiments aimed at reprogramming and controlling the human mind ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

The first application is for people with glioblastoma, an aggressive and terminal kind of brain cancer. (Glioblastoma claimed ...

When does your brain reach adulthood? We're now understanding the many ways the organ continues to mature decades after ...